Close Menu

NEW YORK (360Dx) – Founded in 2014, Transplant Genomics aims to change the transplant diagnostics space by using blood-based noninvasive tests instead of traditional tissue-based methods.

Recently, the Scripps Research Institute was granted patents to the technology that TGI uses for its test. Three years after the two partners began their collaboration, the Mansfield, Massachusetts based-firm is now embarking on a strategy to pierce a market estimated worldwide at $2.5 billion to $3 billion.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.